Filing Details
- Accession Number:
- 0001181431-10-057747
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-26 16:15:49
- Reporting Period:
- 2010-11-23
- Filing Date:
- 2010-11-26
- Accepted Time:
- 2010-11-26 16:15:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1355790 | International Stem Cell Corp | ISCO.OB | Pharmaceutical Preparations (2834) | 204494098 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1382694 | Jeffrey Janus | C/O International Stem Cell Corp. 2595 Jason Court Oceanside CA 92056 | Senior Vice President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-11-23 | 50,000 | $1.72 | 2,091,337 | No | 4 | S | Indirect | Through Family Trust dated 9/17/2008 |
Common Stock | Disposition | 2010-11-24 | 50,000 | $1.60 | 2,041,337 | No | 4 | S | Indirect | Through Family Trust dated 9/17/2008 |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Through Family Trust dated 9/17/2008 |
No | 4 | S | Indirect | Through Family Trust dated 9/17/2008 |
Footnotes
- Sold pursuant to a 10b5-1 sales plan adopted on October 19, 2010.